Clinical Trial Update: Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of BIIB092 in early Alzheimer's disease was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BIIB092

Snippet

Sponsor: Biogen | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2022-11-08